Undisclosed anti-IL-12R multispecific antibody
/ AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
Engineering a conditional CD8+ T cell targeted anti-IL-12R multispecific antibody with optimal therapeutic index
(SITC 2026)
- No abstract available
Oncology
1 to 1
Of
1
Go to page
1